Join to View Full Profile
44 Binney StreetD1230Boston, MA 02115
Phone+1 617-632-3237
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Ross, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Clinical Instructor in Medicine at Dana-Farber Cancer Institute.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2005
University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1999
Certifications & Licensure
MA State Medical License 2003 - 2022
Publications & Presentations
PubMed
- 428 citationsGene Therapy in Patients with Transfusion-Dependent β-ThalassemiaAlexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski, John E.J. Rasko, Jean-Antoine Ribeil
The New England Journal of Medicine. 2018-04-18 - 31 citationsA Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local...Rana R. McKay, Amado J. Zurita, Lillian Werner, Justine Yang Bruce, Michael A. Carducci
Journal of Clinical Oncology. 2016-09-27 - 28 citationsA Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate CancerKevin D. Courtney, Judith Manola, Aymen Elfiky, Robert S. Ross, William Oh
Clinical Genitourinary Cancer. 2015-04-01
Press Mentions
Chutes & Ladders—After Verastem Pit Stop, Bluebird Vet Neumann Lands at KiteFebruary 12th, 2021
Surface Oncology to Present at the 40th Annual Cowen Healthcare ConferenceFebruary 25th, 2020- Clasp Emerges with $150M Series a Financing to Advance T Cell EngagersMarch 21st, 2024
- Join now to see all
